Abstract

Fungal infections represent a growing global health challenge, particularly among immunocompromised individuals, critically ill patients, and those undergoing prolonged antibiotic or immunosuppressive therapy. The clinical microbiology of fungal infections plays a central role in bridging the gap between early diagnosis and effective treatment outcomes. Accurate diagnosis begins with conventional methods such as direct microscopy using potassium hydroxide (KOH) preparations, Gram staining, and culture on selective media like Sabouraud dextrose agar, which remain foundational for identifying common fungal pathogens. However, these approaches are often slow, leading to delays in initiating appropriate therapy. Advances in diagnostic microbiology, including antigen detection assays such as galactomannan and β-D-glucan tests, have significantly improved early detection of invasive fungal infections. Molecular techniques like polymerase chain reaction (PCR), DNA sequencing, and MALDI-TOF mass spectrometry now enable rapid and precise species-level identification, which is critical given the varying antifungal susceptibility profiles among species of Candida, Aspergillus, and Cryptococcus. Despite these improvements, antifungal drug resistance has emerged as a major clinical concern. Mechanisms of resistance include mutations in target enzymes such as ERG11 in azoleresistant Candida species, overexpression of efflux pumps, biofilm-associated tolerance, and alterations in cell wall composition that reduce drug binding. The widespread and sometimes empirical use of antifungal agents has further accelerated resistance development. Clinical microbiology laboratories play a vital role in antifungal susceptibility testing and in guiding evidence-based therapy tailored to local epidemiological trends. Integration of rapid diagnostics with resistance profiling is essential for improving patient outcomes. Ultimately, a comprehensive understanding of fungal pathogenesis, diagnostic innovations, and resistance mechanisms is crucial for managing fungal diseases effectively in modern clinical settings.

Keywords

Microbial infections, fungal infection, MDR